Johnson & Jonson's (JNJ -0.5%) Janssen Phaemaceuticals unit will pay $158M to settle a suit...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

Johnson & Jonson's (JNJ -0.5%) Janssen Phaemaceuticals unit will pay $158M to settle a suit filed by the State of Texas regarding Medicaid overpayments for Janssen's Risperdal drug. Texas had been previously seeking damages of $579M.